Salary increases another sign the phase 1a is going well?The proxy reveals a nice uptick in salaries for our executive team. Some will no doubt argue this is terribly incongruant with the share price and is another indication of a "heads we win, tails you lose" situation at TH. I suspect it has more to do with the price you have to pay for talent these days and the fact that this team has delivered on cancer and the board wants to keep everyone in place so future progress is not stymied by losing key people. My guess is that when they brought John Leasure in, they ahd to pay up and then they had to adjust incumbent executives salaries to be fair. But I really suspect they know they have something potentially quite big in cancer and they want to keep things rolling forward there without any unnecessary disruption to the executive staff.